Approximately 80 more participants are needed for a multisite, Phase 3 clinical trial comparing laparoscopic-assisted versus conventional surgery in patients with stage IIA, Stage IIIA or stage IIIB rectal cancer. 

Eligible participants must have completed their pre-surgery chemotherapy (Xelox™ or fluorouracil-based) and/or pre-surgery radiation therapy within the previous 4 weeks. Read the rest of this entry »